Blind loop syndrome
A condition of small intestine bacterial overgrowth causing malabsorption.
Blind loop syndrome, also called stagnant loop syndrome, happens when the usual bacteria in the small intestine multiply so much that they disrupt normal digestion and absorption. In some instances, harmful non-commensal bacteria also overgrow. Normally, from birth onward, large populations of bacteria live symbiotically in the human gut, and this understanding has led to treatments like probiotics for bowel issues. The problem in blind loop syndrome occurs when bacterial colonies in the upper gastrointestinal tract grow uncontrollably or change in composition, overwhelming the small intestine’s normal processes. This can cause vitamin B12 deficiency, poor fat absorption leading to fatty stools (steatorrhea), deficiencies in fat-soluble vitamins, and damage to the intestinal lining.
Symptoms are often vague but still require careful attention. They include loss of appetite, nausea, flatulence, diarrhea, a feeling of fullness after eating, fatty stools, unintentional weight loss, and general weakness. Because of vitamin and mineral deficiencies from malabsorption, advanced cases should be checked for deficiencies in vitamin B12, folate, iron, and vitamin E.
The condition can arise as a complication of abdominal surgery, inflammatory bowel disease, or scleroderma. Another cause is jejunoileal diverticula. Normally, bacterial overgrowth in the small intestine is prevented by constant peristalsis and the antibacterial effects of gastric juices, pancreatic secretions, and bile. Disruption of any of these factors can lead to bacterial overgrowth. Blind loop syndrome is seen in people with anatomical issues that cause stagnation, and it has also been linked to achlorhydria, dysmotility, fistulae, and strictures. Chronic or high-dose opioid use may contribute by slowing gastric motility. The bacterial overgrowth disrupts digestion, causing malabsorption of bile salts, fats, fat-soluble vitamins, proteins, and carbohydrates, and can damage the intestinal lining through bacteria or their toxic byproducts.
A physical exam may reveal abdominal mass or distention. Useful tests include abdominal X-ray, abdominal CT scan, and contrast enema study.
Treatment follows two main approaches: test-and-treat or treat empirically. The test-and-treat method uses tests like the glucose breath test or jejunal aspiration, though their reliability has been questioned.
- Field
- Gastroenterology
- Known for
- Bacterial overgrowth causing malabsorption and nutrient deficiencies
- Symptoms
- Loss of appetite, nausea, flatulence, diarrhea, fullness after a meal, fatty stools, unintentional weight loss, generalized weakness
- Causes
- Surgical operations of the abdomen, inflammatory bowel disease, scleroderma, jejunoileal diverticula
- Treatment
- Test-and-treat or treat empirically with antibiotics such as tetracyclines, rifaximin, or metronidazole; surgical management for anatomical causes
Lore & Background
Blind loop syndrome is a complication of surgical operations of the abdomen, as well as inflammatory bowel disease or scleroderma. Another cause is jejunoileal diverticula. The overgrowth of bacteria in the small intestine is normally prevented by mechanical and chemical factors including constant peristaltic movement and antibacterial properties of gastric secretions, pancreatic secretions, and bile. Disruption of these factors can lead to bacterial overgrowth, and the syndrome has been found in persons with anatomical anomalies that result in stagnation, as well as in association with achlorhydria, dysmotility, fistulae, and strictures. Chronic or high-dose opioid therapy may contribute by reducing gastric motility.
Reader's Guide
Blind loop syndrome is significant because it illustrates how disruption of normal gut flora balance can lead to serious digestive and absorptive dysfunction. The condition's recognition has led to two main management approaches: test-and-treat, using glucose breath test or jejunal aspiration, and treat empirically, with antibiotics individualized to the patient's circumstances. Tetracyclines have been a mainstay, but recent studies have concluded rifaximin to be very effective, while a study by Di Stefano et al. concluded metronidazole to be more effective than rifaximin. Surgical management is reserved for fixing anatomical causes such as strictures, fistulae, and diverticula. The condition's legacy includes its contribution to understanding small intestinal bacterial overgrowth (SIBO) and the role of probiotics in bowel health.
Did You Know?
- Blind loop syndrome is also known as stagnant loop syndrome.
- It can result from chronic or high-dose opioid therapy by reducing gastric motility.
More in Syndromes 1-24
Spotted an error? Know more?
Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced